TP53 and endometrial cancer: The TransPORTEC Refining Adjuvant treatment IN endometrial cancer Based On molecular features (RAINBO) suite of clinical trials is evaluating the role of adjuvant chemo-radiation with or without a DNA damage response targeting agent in women with p53-abnormal endometrial cancer (39).